Rituximab (Rituxan) | American Journal of Neuroradiology
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome | Pharmacology
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Targeting CD20: Monoclonals of the future - ppt download
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
PV | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Rituxan
Výsledek obrázku pro rituximab mechanism of action | Rheumatoid arthritis diet, Osteoarthritis, Rheumatoid arthritis
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
How the discovery of rituximab impacted the treatment of B-cell non-Ho | JBM
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma: Molecular Therapy - Oncolytics
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy | Oncology
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
PLOS ONE: Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity
Obinutuzumab for the treatment of non-Hodgkin lymphomas
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Saudi Leukemia Net on Twitter: "Mechanism of #rituximAb mediated cell death. Blood 2010 https://t.co/XAQyMS7lOR" / Twitter
Immunosuppressive therapy with rituximab in common variable immunodeficiency | SpringerLink
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Rituximab | Immunopaedia
Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram
